Development of novel therapeutic bone cell products administrable by a minimally invasive technique for the treatment of invalidating bone diseases. Bone disease and reconstruction market is one of the largest healthcare markets in the world, with more than 4M procedures requiring bone grafts annually. Bone Therapeutics is operating in areas where demand for new products is high and competition is low.